UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005134
Receipt number R000006074
Scientific Title Eeffect of rebamipide for ESD-induce ulcer in early gastric cancer
Date of disclosure of the study information 2011/02/24
Last modified on 2013/03/31 14:05:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Eeffect of rebamipide for ESD-induce ulcer in early gastric cancer

Acronym

rebamipide for ESD-induce ulcer

Scientific Title

Eeffect of rebamipide for ESD-induce ulcer in early gastric cancer

Scientific Title:Acronym

rebamipide for ESD-induce ulcer

Region

Japan


Condition

Condition

early gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Useful of rebamipide for ESD-induced ulcer in early gastric cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Endoscopic examination 4 and 8 weeks after ESD

Key secondary outcomes

Clinical symptoms


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

8 weeks treatment of rebamipide 300mg t.i.d

Interventions/Control_2

8 weeks teatment of ransoprazole t.i.d

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients of ESD treatment for early gastric cancer

Key exclusion criteria

Exclusion criteria included patients of other ulcer drugs, or NSAIDs,or aspirin,or anticoagulants,or predonisolone.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name matsui shigenaga

Organization

Kinki university hospital

Division name

gastroenterology

Zip code


Address

377-2,ohno-higashi,osaka-sayama city

TEL

072-366-0221

Email



Public contact

Name of contact person

1st name
Middle name
Last name matsui shigenaga

Organization

Kinki university hospital

Division name

gastroenterology

Zip code


Address

377-2,ohno-higashi,osaka-sayama city

TEL

072-366-0221

Homepage URL


Email

ma2i@med.kindai.ac.jp


Sponsor or person

Institute

Kinki university hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

近畿大学医学部付属病院


Other administrative information

Date of disclosure of the study information

2011 Year 02 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 04 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 06 Month 01 Day

Date trial data considered complete

2012 Year 07 Month 01 Day

Date analysis concluded

2013 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2011 Year 02 Month 24 Day

Last modified on

2013 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006074